Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1751 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Zyto Signs SMP Agreement With Nutri-West

Zyto’s SMP program teams Zyto with nutriceutical suppliers who serve healthcare professionals exclusively. Vaughn Cook, CEO of Zyto, said: “The SMP program is a joint effort between Zyto

Novartis’ Tasigna Wins FDA Priority Review

FDA priority review status is granted to therapies that offer major advances in treatment or provide a treatment where no adequate therapy exists. This status accelerates the standard

GSK Reviews FDA Proposed Label Changes

GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted. The FDA’s

VIRxSYS Presents Results Of HIV Vaccine Study

The study has demonstrated that VRX1023 is capable of achieving control of viral load over the course of four months following a challenge with a pathogenic simian immunodeficiency